Release Date: 17/02/21 13:06 Summary: H1 FY21 Results Release Date and Conference Call details Price Sensitive: No Download Document 185.82KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%